Venturi Wealth Management, LLC Vertex Pharmaceuticals Inc Transaction History

Venturi Wealth Management, LLC

$1.77 Billion
Q1 2025

A detailed history of Venturi Wealth Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Venturi Wealth Management, LLC holds 5,905 shares of VRTX stock, worth $2.57 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

5,905

Previous 6,112 3.39%

Holding current value

$2.57 Million

Previous $2.46 Million 16.29%

% of portfolio

0.16%

Previous 0.13%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 06, 2025	SELL	$402.49 - $513.76 $83,315 - $106,348	-207 Reduced 3.39%	5,905 $2.86 Million
Q4 2024 Jan 31, 2025	BUY	$396.64 - $516.74 $1.42 Million - $1.85 Million	3,580 Added 141.39%	6,112 $2.46 Million
Q3 2024 Nov 04, 2024	BUY	$460.0 - $505.78 $18,400 - $20,231	40 Added 1.61%	2,532 $1.18 Million
Q2 2024 Jul 19, 2024	BUY	$392.81 - $485.53 $74,633 - $92,250	190 Added 8.25%	2,492 $1.17 Million
Q1 2024 Apr 23, 2024	BUY	$407.69 - $446.08 $3,669 - $4,014	9 Added 0.39%	2,302 $962,000
Q4 2023 Jan 23, 2024	BUY	$343.0 - $410.68 $8,232 - $9,856	24 Added 1.06%	2,293 $932,000
Q3 2023 Nov 02, 2023	BUY	$338.18 - $362.46 $27,730 - $29,721	82 Added 3.75%	2,269 $789,000
Q2 2023 Jul 24, 2023	SELL	$314.42 - $351.91 $1,886 - $2,111	-6 Reduced 0.27%	2,187 $769,000
Q1 2023 May 02, 2023	SELL	$283.23 - $323.1 $60,894 - $69,466	-215 Reduced 8.93%	2,193 $690,000
Q4 2022 Jan 31, 2023	BUY	$285.76 - $321.48 $68,296 - $76,833	239 Added 11.02%	2,408 $695,000
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $56,682 - $63,244	207 Added 10.55%	2,169 $628,000
Q2 2022 Aug 12, 2022	SELL	$234.96 - $292.55 $133,927 - $166,753	-570 Reduced 22.51%	1,962 $553,000
Q1 2022 May 13, 2022	BUY	$221.42 - $260.97 $173,150 - $204,078	782 Added 44.69%	2,532 $661,000
Q4 2021 Feb 08, 2022	SELL	$177.01 - $223.45 $6,018 - $7,597	-34 Reduced 1.91%	1,750 $384,000
Q3 2021 Oct 19, 2021	BUY	$181.39 - $202.99 $274,987 - $307,732	1,516 Added 565.67%	1,784 $324,000
Q3 2019 Oct 29, 2019	BUY	$166.23 - $187.09 $44,549 - $50,140	268 New	268 $45,000
Q1 2019 May 14, 2019	SELL	$163.73 - $194.7 $278,995 - $331,768	-1,704 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$151.91 - $192.21 $258,854 - $327,525	1,704 New	1,704 $279,000

Others Institutions Holding VRTX

# of Institutions

1,830

Shares Held

233M

Call Options Held

1.38M

Put Options Held

1.08M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $112B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Venturi Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Venturi Wealth Management, LLC with notifications on news.

Account

Venturi Wealth Management, LLC Vertex Pharmaceuticals Inc Transaction History